I'm involved in the exciting field of CAR T-cell therapy research. This innovative treatment involves genetically engineering patients' own T-cells, a type of white blood cell, to better recognize and attack cancer cells. Specifically, I work on designing and optimizing the chimeric antigen receptors (CARs) that are introduced into the T-cells, enhancing their cancer-fighting abilities. My interest lies in making these therapies safer and more effective, with the ultimate goal of improving outcomes for people battling various types of cancer. It's a blend of cutting-edge science and profound patient impact that drives my passion in this work.